We are live on ! Find out more
GMVD

G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD

Delisted

GMVD was delisted on the 23rd of August, 2023.

Back to rankings

6 hedge funds and large institutions have $217K invested in G Medical Innovations Holdings Ltd. Ordinary Shares in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

34% more capital invested

Capital invested by funds: $162K → $217K (+$55K)

57% less funds holding

Funds holding: 14 → 6 (-8)

80% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 10

Holders
6
Holders Change
-8
Holders Change %
-57.14%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$275K
2
UBS Group
UBS Group
Switzerland
+$10.3K
3
Bank of America
Bank of America
North Carolina
+$5.84K
4
Macquarie Group
Macquarie Group
Australia
+$5

Top Sellers

Rank Fund Capital Flow
1
S
swisspartners
Liechtenstein
-$40K
2
SSA
Schonfeld Strategic Advisors
New York
-$16K
3
Goldman Sachs
Goldman Sachs
New York
-$15K
4
VF
Virtu Financial
New York
-$15K
5
Jane Street
Jane Street
New York
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
1
JP Morgan Chase
New York
$196K +$275K +58,445 +3,400%
Macquarie Group
2
Macquarie Group
Australia
$9.51K +$5 +1 +0%
UBS Group
3
UBS Group
Switzerland
$7.19K +$10.3K +2,193 New
Bank of America
4
Bank of America
North Carolina
$4.07K +$5.84K +1,240 New
HWM
5
HighMark Wealth Management
Minnesota
$154 – – –
HI
6
Harbour Investments
Wisconsin
$66 -$5 -1 -5%
S
7
swisspartners
Liechtenstein
– -$40K -4,857 Closed
SSA
8
Schonfeld Strategic Advisors
New York
– -$16K -1,914 Closed
Goldman Sachs
9
Goldman Sachs
New York
– -$15K -1,867 Closed
VF
10
Virtu Financial
New York
– -$15K -1,810 Closed
TSS
11
Two Sigma Securities
New York
– -$11K -1,407 Closed
Jane Street
12
Jane Street
New York
– -$11K -1,315 Closed
Geode Capital Management
13
Geode Capital Management
Massachusetts
– -$9K -1,113 Closed
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
– -$3K -369 Closed
IA
15
IFG Advisors
Missouri
– -$2K -286 Closed
IA
16
IFG Advisory
Georgia
– -$2K -286 Closed

GMVD Hedge Fund Activity: Q4 2022 in Review

6 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) for Q4 2022, worth a combined $217K — up 34% from $162K a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of GMVD and 2 opened new positions — a net loss of 8 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was JP Morgan Chase, adding an estimated $275K. The largest seller was swisspartners, exiting entirely with an estimated $40K sold.

  • 6 institutional investors held G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) as of Q4 2022, down from 14 in Q3 2022.
  • Funds reported $217K of G Medical Innovations Holdings Ltd. Ordinary Shares stock for Q4 2022, up 34% quarter-over-quarter.
  • 2 funds opened new G Medical Innovations Holdings Ltd. Ordinary Shares positions in Q4 2022 and 10 closed out, a net change of -8 holders.
  • The largest G Medical Innovations Holdings Ltd. Ordinary Shares buyer in Q4 2022 was JP Morgan Chase, an estimated $275K added.
  • The largest G Medical Innovations Holdings Ltd. Ordinary Shares seller in Q4 2022 was swisspartners, an estimated $40K sold.

Based on aggregated 13F filings for Q4 2022.